Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
---|---|
Information provided by: | National Institutes of Health Clinical Center (CC) |
ClinicalTrials.gov Identifier: | NCT00001159 |
Participants in this study will be patients diagnosed with or suspected to have a thyroid function disorder. These conditions may include: hypothyroidism, hyperthyroidism, thyroid hormone resistance, Graves' Dermopathy, and thyroid-stimulating hormone (TSH) secreting pituitary adenomas.
The main purpose of this study is to further understand the natural history, clinical presentation, and genetics of thyroid function disorders. Many of the tests performed are in the context of standard medical care that is offered to all patients with thyroid function disorders. In addition, blood and tissue samples may be taken for research and genetic studies.
Condition |
---|
Hyperthyroidism Hypothyroidism Pituitary Neoplasm |
Study Type: | Observational |
Official Title: | Evaluation of Patients With Thyroid Function Disorders |
Study Start Date: | January 1977 |
Patients with thyroid function abnormalities (hyperthyroidism, hypothyroidism) are studied and treated in this protocol. A limited number of patients with a personal history of signs, symptoms or laboratory studies consistent with thyroid dysfunction or a strong family history of thyroid abnormalities are also enrolled. Patients undergo routine history and physical examination, standard endocrine blood and urine tests, a standard TRH test, thyroid nuclear medicine scans, thyroidal radioiodine (RAI) or technetium (99mTc) uptake measurements, as well as X-ray, computed tomography (CT) or magnetic resonance imaging (MRI) studies or other standard diagnostic procedures, as clinically indicated. Patients will be screened for entry into other research studies.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Patients of any age with known or suspected thyroid abnormalities may be included in this study. These disorders can be broadly defined as hyper- or hypothyroid states and laboratory abnormalities.
Contact: Patient Recruitment and Public Liaison Office | (800) 411-1222 | prpl@mail.cc.nih.gov |
Contact: TTY | 1-866-411-1010 |
United States, Maryland | |
National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
Bethesda, Maryland, United States, 20892 |
Study ID Numbers: | 770002, 77-DK-0002 |
Study First Received: | November 3, 1999 |
Last Updated: | October 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00001159 |
Health Authority: | United States: Federal Government |
Thyroid Pituitary Tumors Hormone Resistance Hyperthyroidism |
Hypothyroidism Thyroid-Stimulating Hormone Secreting Pituitary Adenomas TSH Secreting Pituitary Adenomas Graves' Dermopathy |
Hypothalamic Diseases Pituitary Diseases Endocrine System Diseases Central Nervous System Diseases Pituitary Neoplasms Central Nervous System Neoplasms Brain Diseases Supratentorial Neoplasms |
Brain Neoplasms Hypothyroidism Endocrinopathy Adenoma Thyroid Diseases Hyperthyroidism Nervous System Neoplasms Endocrine Gland Neoplasms |
Neoplasms Neoplasms by Site Hypothalamic Neoplasms Nervous System Diseases |